217-558-8 | Sigma-Aldrich

Quality Control Range Sheet- A6041-102and A6041-202

Control 2 1978 - 4108 pg/mL Granzyme A Control 1 13 - 28 pg/mL IL-12(p70) Control 1 269 - 558 pg/mL Control 2 66 - 138 pg/mL

Quality Control Ranges: Milliplex Human Cytokine / Chemokine Immunoassay

1 107 – 223 pg/mL IL-12p70 Control 1 114 – 237 pg/mL Control 2 524 – 1089 pg/mL Control 2 558 – 1159 pg/mL

XP725 Antibody Number-Lot Number 071M4826

506 507 508 529 530 531 532 553 554 555 556 6.2 485 486 487 488 509 510 511 512 533 534 535 536 557 558 559 560 6.3 489 490 491 492 513 514 515 516 537 538 539 540 561

Quality Control Range Sheet- HCC-121A and HCC-221A

1 107 – 223 pg/mL IL-12p70 Control 1 114 – 237 pg/mL Control 2 524 – 1089 pg/mL Control 2 558 – 1159 pg/mL

Protocol: Human PYY (3-36) Specific RIA Kit

performance are expressed as Mean + Standard Deviation. ED80 = 93 + 3 ED50 = 230 + 15 ED20 = 558 + 44 C. Specificity The specificity (also

Cytoskeletal Signaling Antibodies, Reagents and Kits

N-SH2 UB93-3 H M R IP WB Sup M IgG 200 µL 05-217 Anti-PI3 Kinase, p85a, Rb Mab H M R FC IP WB Rb IgG 100 µL 04-403 IC IH(P) Anti-PI 3-Kinase p85α 8-2D-4D H M

XP725 Antibody List Lot 089K4791

M NP_004553.2 y y y 551 Par-4 (Prostate Apoptosis Response-4) P5367 5074 PAWR P NP_002574.2 y y y 558 Proliferating Cell Nuclear Antigen (PCNA) P8825 5111 PCNA M NP_002583.1 y n/d n/d 593 Platelet-Derived

XP725 Antibody List Lot 129K4831

M NP_004553.2 y y y 551 Par-4 (Prostate Apoptosis Response-4) P5367 5074 PAWR P NP_002574.2 y y y 558 Proliferating Cell Nuclear Antigen (PCNA) P8825 5111 PCNA M NP_002583.1 y n/d n/d 593 Platelet-Derived

XP725 Antibody List Lot 129K4830

M NP_004553.2 y y y 551 Par-4 (Prostate Apoptosis Response-4) P5367 5074 PAWR P NP_002574.2 y y y 558 Proliferating Cell Nuclear Antigen (PCNA) P8825 5111 PCNA M NP_002583.1 y n/d n/d 593 Platelet-Derived

XP725 Worksheet for Lot Number 071M4826

F1043 556 3 4 4 4 Filensin F1043 557 3 4 4 5 FKHR FOXO1a F6928 558 3 4 4 6 FKHR FOXO1a F6928 559 3 4 4 7 FKHRL1 FOXO3a F2178 560 3 4 4 8 FKHRL1 FOXO3a F2178 561 3 4 5 1 FKHRL1

List of Antibodies

Parkin P6248 M y y y 555 PARP P7605 P y n/d n/d 556 Paxillin P1093 M y n/d y 557 PCAF P7493 P y n/d n/d 558 Proliferating Cell Nuclear Antigen (PCNA) P8825 M y n/d n/d 559 PDK 1 P3110 P y n/d

XP725 Antibody List

360820 Pxn,PXN NP_002850.1,NP_001012147.1 M y n/d y 557 PCAF P7493 8850 PCAF NP_003875.3 P y n/d n/d 558 Proliferating Cell Nuclear Antigen (PCNA) P8825 5111 PCNA NP_872590.1 M y n/d n/d 559 PDK 1 P3110 5170

XP725 Antibody List 013M4793

360820 Pxn,PXN NP_002850.1,NP_001012147.1 M y n/d y 557 PCAF P7493 8850 PCAF NP_003875.3 P y n/d n/d 558 Proliferating Cell Nuclear Antigen (PCNA) P8825 5111 PCNA NP_872590.1 M y n/d n/d 559 PDK 1 P3110 5170

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

10 µg 14-604 PI3 Kinase (p110α/p85a), active KA 20 µg 14-602 PI3 Kinase (p120γ) KA 20 µg 14-558 Wortmannin, (PI3 Kinase inhibitor) KA 1 mg 12-338 Assay PI 3-Kinase HTRF Assay KA 1 plate

Halal Certificate

W344400 C53468 HC-23SISH60 557. D-Octalactone, Mixture Of Isomers W321405 C41920 HC-23SIFI65 558. D-RIBOSE, NATURAL W379312 B88298 HC-23SI1689 559. d-Tridecalactone W468501 C29022 HC-23SIUI12

Halal Certificate

W344400 C53468 HC-22SI8281 557. D-Octalactone, Mixture Of Isomers W321405 C41920 HC-22SIFN86 558. D-RIBOSE, NATURAL W379312 B88298 HC-22SIAP11 559. d-Tridecalactone W468501 C29022 HC-22SIYE33